Patents by Inventor Yui HAYASHI

Yui HAYASHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11890372
    Abstract: The present invention provides an infusion preparation that is inhibited from generation of unwanted insoluble matter after mixing of two liquids of the infusion preparation in long-term storage. More specifically, the present invention provides an infusion preparation comprising two chambers separated by a communicably openable partition, a first chamber containing a first-chamber infusion comprising a fat emulsion and further comprising at least one member selected from the group consisting of amino acids that have a buffer action, divalent organic acids, and trivalent organic acids, a second chamber containing a second-chamber infusion comprising an amino acid and at least calcium as an electrolyte, wherein a total concentration of the amino acids that have a buffer action, divalent organic acids, and trivalent organic acids in the first-chamber infusion is 0.15 to 0.5 g/L, and a mixture of the first- and second-chamber infusions has a pH of 6.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: February 6, 2024
    Assignee: OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Seiji Tani, Seiji Fujita, Teru Nakai, Yasuhiro Kiuchi, Miyuki Yamanaka, Yui Hayashi, Hiroshi Kanno, Yu Saruwatari
  • Publication number: 20210007975
    Abstract: The present invention provides an infusion preparation that is inhibited from generation of unwanted insoluble matter after mixing of two liquids of the infusion preparation in long-term storage. More specifically, the present invention provides an infusion preparation comprising two chambers separated by a communicably openable partition, a first chamber containing a first-chamber infusion comprising a fat emulsion and further comprising at least one member selected from the group consisting of amino acids that have a buffer action, divalent organic acids, and trivalent organic acids, a second chamber containing a second-chamber infusion comprising an amino acid and at least calcium as an electrolyte, wherein a total concentration of the amino acids that have a buffer action, divalent organic acids, and trivalent organic acids in the first-chamber infusion is 0.15 to 0.5 g/L, and a mixture of the first- and second-chamber infusions has a pH of 6.
    Type: Application
    Filed: March 13, 2018
    Publication date: January 14, 2021
    Applicant: OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Seiji TANI, Seiji FUJITA, Teru NAKAI, Yasuhiro KIUCHI, Miyuki YAMANAKA, Yui HAYASHI, Hiroshi KANNO, Yu SARUWATARI